Immunogenicity and safety of combined measles-mumps-rubella-varicella vaccine using new measles and rubella working seeds in healthy children in Taiwan and Singapore: A phase II, randomized, double-blind trial

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 6, 2013, Pages 1308-1315

  Huang, Li Min ^a   Lee, Bee Wah ^b   Chan, Poh Chong ^c   Povey, Michael ^d   Henry, Ouzama ^e  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^d GSK   (Belgium)

^e GLAXOSMITHKLINE   (United States)

Author keywords

Immunogenicity; MMRV vaccine; Newly established working seed virus stock; Safety; Singapore; Taiwan

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE;

ACUTE GASTROENTERITIS; ANTIBODY TITER; ARTICLE; BRONCHIOLITIS; CHICKENPOX; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG FEVER; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; FEBRILE CONVULSION; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOGENICITY; INCIDENCE; INFANT; INJECTION SITE COLORATION; MALE; MEASLES; MUCOCUTANEOUS LYMPH NODE SYNDROME; MUMPS; NORMAL HUMAN; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RUBELLA; SEIZURE; SEROCONVERSION; SINGAPORE; SINGAPOREAN; TAIWAN; TAIWANESE; TONSILLITIS; UPPER RESPIRATORY TRACT INFECTION; VIRUS ENCEPHALITIS;

IMMUNOGENICITY; MMRV VACCINE; NEWLY ESTABLISHED WORKING SEED VIRUS STOCK; SAFETY; SINGAPORE; TAIWAN;

ANTIBODIES, VIRAL; CHICKENPOX VACCINE; DOUBLE-BLIND METHOD; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; FLUORESCENT ANTIBODY TECHNIQUE; HEALTHY VOLUNTEERS; HUMANS; INFANT; MALE; MEASLES-MUMPS-RUBELLA VACCINE; SINGAPORE; TAIWAN; VACCINATION; VACCINES, COMBINED;

EID: 84880682799     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.24035     Document Type: Article

References (28)

1. Measles vaccines: WHO position paper. Wkly Epidemiol Rec 2009; 84:349-60; PMID:19714924.
2. Mumps virus vaccines. WHO position paper. Wkly Epidemiol Rec 2007; 82:49-60.
3. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec 2011; 86:301-16; PMID:21766537.
4. Varicella vaccines. WHO position paper. Wkly Epidemiol Rec 1998; 73:241-8; PMID:9715106.
5. Centers for Disease Control and Prevention (CDC). Progress in reducing measles mortality-worldwide, 1999-2003. MMWR Morb Mortal Wkly Rep 2005; 54:200-3; PMID:15744229.
6. Vesikari T, Sadzot-Delvaux C, Rentier B, Gershon A. Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine. Pediatr Infect Dis J 2007; 26:632-8; PMID:17596807; http://dx.doi.org/10.1097/INF. 0b013e3180616c8f.
7. Czajka H, Schuster V, Zepp F, Esposito S, Douha M, Willems P. A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile. Vaccine 2009; 27:6504-11; PMID:19665608; http://dx.doi.org/10.1016/j.vaccine. 2009.07.076.
8. Quian J, Rüttimann R, Romero C, Dall'Orso P, Cerisola A, Breuer T, et al. Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005. Arch Dis Child 2008; 93:845-50; PMID:18456699; http://dx.doi.org/10. 1136/adc.2007.126243.
9. Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics 2011; 128:214-20; PMID:21788222; http://dx.doi.org/10.1542/peds.2010-3385.
10. Lin CC, Yang CY, Shih CT, Chen BH, Huang YL. Rubella seroepidemiology and catch-up immunization among pregnant women in Taiwan: comparison between women born in Taiwan and immigrants from six countries in Asia Am J Trop. Med Hyg (Geneve) 2010; 82:40-4; http://dx.doi.org/10.4269/ajtmh.2010.09-0302.
11. Chang LY, Huang LM, Chang IS, Tsai FY. Epidemiological characteristics of varicella from 2000 to 2008 and the impact of nationwide immunization in Taiwan. BMC Infect Dis 2011; 11:352; PMID:22176638; http://dx.doi.org/10.1186/ 1471-2334-11-352.
12. Huang WC, Huang LM, Chang IS, Tsai FY, Chang LY. Varicella breakthrough infection and vaccine effectiveness in Taiwan. Vaccine 2011; 29:2756-60; PMID:21315697; http://dx.doi.org/10.1016/j.vaccine.2011.01.092.
13. Chen JH, Tsou TP, Liu DP. Measles resurgence in Taiwan-lessons learned. J Formos Med Assoc 2009; 108:267-9; PMID:19369172; http://dx.doi.org/10.1016/ S0929-6646(09)60065-6.
14. Cheng WY, Yang CF, Hou YT, Wang SC, Chang HL, Chiu HY, et al. Imported measles and implications for its elimination in Taiwan. Emerg Infect Dis 2011; 17:1523-6; PMID:21801641.
15. Jean-Jasmin LM, Lynette SP, Stefan M, Kai CS, Chew FT, Wah LB. Economic burden of varicella in Singapore-a cost benefit estimate of implementation of a routine varicella vaccination. Southeast Asian J Trop Med Public Health 2004; 35:693-6; PMID:15689089.
16. Rentier B, Gershon AA; European Working Group on Varicella. Consensus: varicella vaccination of healthy children-a challenge for Europe. Pediatr Infect Dis J 2004; 23:379-89; PMID:15131459; http://dx.doi.org/10.1097/01.inf. 0000122606.88429.8f.
17. Nolan T, McIntyre P, Roberton D, Descamps D. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine. Vaccine 2002; 21:281-9; PMID:12450703; .
18. Knuf M, Habermehl P, Zepp F, Mannhardt W, Kuttnig M, Muttonen P, et al. Immunogenicity and safety of two doses of tetravalent measles-mumpsrubella- varicella vaccine in healthy children. Pediatr Infect Dis J 2006; 25:12-8; PMID:16395096; http://dx.doi.org/10.1097/01.inf.0000195626.35239.58.
19. Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, et al. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubellavaricella vaccine in healthy children during the second year of life. Pediatr Infect Dis J 2008; 27:724-30; PMID:18600190; http://dx.doi.org/10.1097/INF.0b013e318170bb22.
20. Rümke HC, Loch HP, Hoppenbrouwers K, Vandermeulen C, Malfroot A, Helm K, et al. Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses. Vaccine 2011; 29:3842-9; PMID:21382484; http://dx.doi.org/10.1016/j.vaccine.2011.02.067.
21. Goh P, Lim FS, Han HH, Willems P. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age. Infection 2007; 35:326-33; PMID:17710370; http://dx.doi.org/10.1007/s15010-007-6337-z.
22. Centers for disease control and prevention: Measles. In: Atkinson W, Hamborsky J, McIntyre L, Wolfe S, (eds.): Epidemiology and prevention of vaccine-preventable diseases (9th edn). Public Health Foundation, Washington DC, 2006; 125-44.
23. Jacobsen SJ, Ackerson BK, Sy LS, Tran TN, Jones TL, Yao JF, et al. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine 2009; 27:4656-61; PMID:19520201; http://dx.doi.org/10.1016/j.vaccine. 2009.05.056.
24. Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, et al.; Vaccine Safety Datalink. Measlesmumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 2010; 126:e1-8; PMID:20587679; http://dx.doi.org/10.1542/peds.2010-0665.
25. Blatter MM, Klein NP, Shepard JS, Leonardi M, Shapiro S, Schear M, et al. Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age. Pediatr Infect Dis J 2012; 31:e133-40; PMID:22622699; http://dx.doi.org/10.1097/INF.0b013e318259fc8a.
26. Committee on Infectious Diseases. Policy statement-Prevention of varicella: update of recommendations for use of quadrivalent and monovalent varicella vaccines in children. Pediatrics 2011; 128:630-2; PMID:21873692; http://dx.doi.org/10.1542/peds.2011-1968.
27. Berg AT, Shinnar S, Hauser WA, Alemany M, Shapiro ED, Salomon ME, et al. A prospective study of recurrent febrile seizures. N Engl J Med 1992; 327:1122-7; PMID:1528207; http://dx.doi.org/10.1056/NEJM199210153271603.
28. Chen SY, Tsai CN, Lai MW, Chen CY, Lin KL, Lin TY, et al. Norovirus infection as a cause of diarrheaassociated benign infantile seizures. Clin Infect Dis 2009; 48:849-55; PMID:19239351; http://dx.doi.org/10.1086/597256.